SCHEMBL1259537

SCHEMBL1259537

C=[C]CC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL283784 0.72
SCHEMBL409162 0.69
SCHEMBL618275 0.69
SCHEMBL8627389 0.69
SCHEMBL25786 0.69
SCHEMBL8602873 0.69
SCHEMBL836144 0.69
Butanone SCHEMBL10630254 0.67 ALDH1A1 (0.67)
SCHEMBL2235099 0.67
SCHEMBL86002 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3565905-A1 STEPWISE SEQUENCING BY NON-LABELED REVERSIBLE TERMINATORS OR NATURAL NUCLEOTIDES MGI Tech Co., Ltd. (CN) 2019-11-13 EP claimed
WO-2018129214-A1 STEPWISE SEQUENCING BY NON-LABELED REVERSIBLE TERMINATORS OR NATURAL NUCLEOTIDES COMPLETE GENOMICS, INC. (US) 2018-07-12 WO claimed
EP-4112741-A1 STEPWISE SEQUENCING BY NON-LABELED REVERSIBLE TERMINATORS OR NATURAL NUCLEOTIDES MGI Tech Co., Ltd. (CN) 2023-01-04 EP disclosed
EP-2464623-A1 THE RING OPENING OF LACTONES AND LACTAMS Novartis AG (CH) 2012-06-20 EP disclosed
WO-2011019789-A1 THE RING OPENING OF LACTONES AND LACTAMS NOVARTIS AG (CH) 2011-02-17 WO disclosed
WO-2003103653-A1 METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO disclosed
WO-2003103652-A1 METHODS OF TREATING ALZHEIMER’S DISEASE USING AROMATICALLY SUBSTITUTED ω-AMINO-ALKANOIC ACID AMIDES AND ALKANOIC ACID DIAMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO disclosed
US-5753652-A Antiretroviral hydrazine derivatives NOVARTIS CORPORATION (US) 1998-05-19 US disclosed
EP-0815081-A1 PIPERIDINYL-2-ALKYL SUBST. LINEAR POLYAMINES FOR THE REDUCTION OF INTRACELLULAR, ENDOGENIC POLYAMINE LEVELS SUCH AS PUTRESCINE, SPERMIDINE AND SPERMINE, AND THEIR IMPACT ON CELL PROLIFERATION Novartis AG (CH) 1998-01-07 EP disclosed
EP-0808309-A1 IMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS S-ADENOSYLMETHIONINE DECARBOXYLASE (=SAMDC) INHIBITORS Novartis AG (CH) 1997-11-26 EP disclosed
EP-0775204-A1 ANTITUMOR ANTISENSE OLIGONUCLEOTIDES Novartis AG (CH) 1997-05-28 EP disclosed
EP-0110826-A1 6-Hydroxy lower alkyl penem compounds, process for their preparation, pharmaceutical compositions containing them and their use CIBA-GEIGY AG (CH) 1984-06-13 EP disclosed
EP-0109362-A1 Hetereocyclic compounds, process for their preparation, pharmaceutical compositions containing them and their use CIBA-GEIGY AG (CH) 1984-05-23 EP disclosed
EP-0097127-A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1983-12-28 EP disclosed
EP-0076452-A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1983-04-13 EP disclosed
EP-0070803-A2 Antibiotically active aminotriazolylcephalosporin derivatives and their preparation CIBA-GEIGY AG (CH) 1983-01-26 EP disclosed
EP-0054512-A2 Cephalosporin esters, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1982-06-23 EP disclosed
EP-0046734-A2 Aminohydroxyphenyl derivatives of cephalosporins, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1982-03-03 EP disclosed
EP-0034347-A2 Derivatives of aldohexoses, intermediates, process for their production, preparations containing such compositions and their use CIBA-GEIGY AG (CH) 1981-08-26 EP disclosed
EP-0025017-A1 Polyazathia compounds, process for their preparation, pharmaceutical preparations containing such compounds and use of the latter CIBA-GEIGY AG (CH) 1981-03-11 EP disclosed